{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:13:14Z","timestamp":1771423994057,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270345"],"award-info":[{"award-number":["82270345"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Capital\u2019s Funds for Health Improvement and Research","award":["CFH2024\u20131-2061"],"award-info":[{"award-number":["CFH2024\u20131-2061"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-026-03882-3","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T07:24:32Z","timestamp":1769498672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ceramide-based machine learning models for the diagnosis of unstable angina: a prospective multicenter study"],"prefix":"10.1186","volume":"31","author":[{"given":"Zhijiang","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanli","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengdan","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guidong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"3882_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.117.004227","author":"PD Adamson","year":"2018","unstructured":"Adamson PD, Hunter A, Madsen DM, Shah ASV, McAllister DA, Pawade TA, et al. High-sensitivity cardiac troponin I and the diagnosis of coronary artery disease in patients with suspected angina pectoris. Circ Cardiovasc Qual Outcomes. 2018. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.117.004227.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"3882_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/ejhf.2282","volume":"23","author":"A Yafasova","year":"2021","unstructured":"Yafasova A, Butt JH, R\u00f8rth R. Troponin: an important prognostic biomarker in patients with heart failure and reduced ejection fraction? Eur J Heart Fail. 2021;23:1539\u201340. https:\/\/doi.org\/10.1002\/ejhf.2282.","journal-title":"Eur J Heart Fail"},{"key":"3882_CR3","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1136\/heartjnl-2018-314305","volume":"105","author":"C Puelacher","year":"2019","unstructured":"Puelacher C, Gugala M, Adamson PD, Shah A, Chapman AR, Anand A, et al. Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction. Heart. 2019;105:1423\u201331. https:\/\/doi.org\/10.1136\/heartjnl-2018-314305.","journal-title":"Heart"},{"key":"3882_CR4","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/01.ATV.0000077207.49221.06","volume":"23","author":"JK Hakala","year":"2003","unstructured":"Hakala JK, Oksjoki R, Laine P, Du H, Grabowski GA, Kovanen PT, et al. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2003;23:1430\u20136. https:\/\/doi.org\/10.1161\/01.ATV.0000077207.49221.06.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3882_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080262","volume":"8","author":"VN Sukhorukov","year":"2020","unstructured":"Sukhorukov VN, Khotina VA, Chegodaev YS, Ivanova E, Sobenin IA, Orekhov AN. Lipid metabolism in macrophages: focus on atherosclerosis. Biomedicines. 2020;8:262. https:\/\/doi.org\/10.3390\/biomedicines8080262.","journal-title":"Biomedicines"},{"key":"3882_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1161\/ATVBAHA.118.311199","volume":"38","author":"JW Meeusen","year":"2018","unstructured":"Meeusen JW, Donato LJ, Bryant SC, Baudhuin LM, Berger PB, Jaffe AS. Plasma Ceramides. Arterioscler Thromb Vasc Biol. 2018;38:1933\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311199.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3882_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/eurheartj\/eht484","volume":"35","author":"JM Cheng","year":"2014","unstructured":"Cheng JM, Garcia-Garcia HM, de Boer SPM, Kardys I, Heo JH, Akkerhuis KM, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J. 2014;35:639\u201347. https:\/\/doi.org\/10.1093\/eurheartj\/eht484.","journal-title":"Eur Heart J"},{"key":"3882_CR8","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1172\/JCI131838","volume":"130","author":"AM Poss","year":"2020","unstructured":"Poss AM, Maschek JA, Cox JE, Hauner BJ, Hopkins PN, Hunt SC, et al. Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease. J Clin Invest. 2020;130:1363\u201376. https:\/\/doi.org\/10.1172\/JCI131838.","journal-title":"J Clin Invest"},{"key":"3882_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/eurheartj\/ehz387","volume":"41","author":"M Hilvo","year":"2020","unstructured":"Hilvo M, Meikle PJ, Pedersen ER, Tell GS, Dhar I, Brenner H, et al. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients. Eur Heart J. 2020;41:371\u201380. https:\/\/doi.org\/10.1093\/eurheartj\/ehz387.","journal-title":"Eur Heart J"},{"key":"3882_CR10","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/eurheartj\/ehw148","volume":"37","author":"R Laaksonen","year":"2016","unstructured":"Laaksonen R, Ekroos K, Sysi-Aho M, Hilvo M, Vihervaara T, Kauhanen D, et al. Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol. Eur Heart J. 2016;37:1967\u201376. https:\/\/doi.org\/10.1093\/eurheartj\/ehw148.","journal-title":"Eur Heart J"},{"key":"3882_CR11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/eurheartj\/ehad161","volume":"44","author":"NS Nurmohamed","year":"2023","unstructured":"Nurmohamed NS, Kraaijenhof JM, Mayr M, Nicholls SJ, Koenig W, Catapano AL, et al. Proteomics and lipidomics in atherosclerotic cardiovascular disease risk prediction. Eur Heart J. 2023;44:1594\u2013607. https:\/\/doi.org\/10.1093\/eurheartj\/ehad161.","journal-title":"Eur Heart J"},{"key":"3882_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237\u201369. https:\/\/doi.org\/10.1093\/eurheartj\/ehy462.","journal-title":"Eur Heart J"},{"key":"3882_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2016;37:267\u2013315. https:\/\/doi.org\/10.1093\/eurheartj\/ehv320.","journal-title":"Eur Heart J"},{"key":"3882_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425.","journal-title":"Eur Heart J"},{"key":"3882_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1177765","author":"L Zhang","year":"2023","unstructured":"Zhang L, Tan D, Zhang Y, Ding Y, Liang H, Zhang G, et al. Ceramides and metabolic profiles of patients with acute coronary disease: a cross-sectional study. Front Physiol. 2023. https:\/\/doi.org\/10.3389\/fphys.2023.1177765.","journal-title":"Front Physiol"},{"key":"3882_CR16","unstructured":"Ceramide Risk Prediction Model Web Interface. 2025. https:\/\/ceramide-app-app-lvhtg9uaayp7n4jcqnvcle.streamlit.app\/. Accessed 17 Aug 2025"},{"key":"3882_CR17","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.ATV.20.7.1777","volume":"20","author":"H Gierens","year":"2000","unstructured":"Gierens H, Nauck M, Roth M, Schinker R, Schu\u0308rmann C, Scharnagl H, et al. Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements. Arterioscler Thromb Vasc Biol. 2000;20:1777\u201383. https:\/\/doi.org\/10.1161\/01.ATV.20.7.1777.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3882_CR18","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1161\/ATVBAHA.112.251538","volume":"32","author":"Z Li","year":"2012","unstructured":"Li Z, Fan Y, Liu J, Li Y, Huan C, Bui HH, et al. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2012;32:1577\u201384. https:\/\/doi.org\/10.1161\/ATVBAHA.112.251538.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3882_CR19","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1194\/jlr.M600040-JLR200","volume":"47","author":"J Dong","year":"2006","unstructured":"Dong J, Liu J, Lou B, Li Z, Ye X, Wu M, et al. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice. J Lipid Res. 2006;47:1307\u201314. https:\/\/doi.org\/10.1194\/jlr.M600040-JLR200.","journal-title":"J Lipid Res"},{"key":"3882_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/823071","volume":"2014","author":"W Li","year":"2014","unstructured":"Li W, Yang X, Xing S, Bian F, Yao W, Bai X, et al. Endogenous ceramide contributes to the transcytosis of oxLDL across endothelial cells and promotes its subendothelial retention in vascular wall. Oxid Med Cell Longev. 2014;2014:1\u201311. https:\/\/doi.org\/10.1155\/2014\/823071.","journal-title":"Oxid Med Cell Longev"},{"key":"3882_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.freeradbiomed.2012.05.026","volume":"53","author":"D Gao","year":"2012","unstructured":"Gao D, Pararasa C, Dunston CR, Bailey CJ, Griffiths HR. Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. Free Radic Biol Med. 2012;53:796\u2013806. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.026.","journal-title":"Free Radic Biol Med"},{"key":"3882_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diabet.2019.07.006","volume":"46","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Bonapace S, Lunardi G, Canali G, Dugo C, Vinco G, et al. Associations between specific plasma ceramides and severity of coronary-artery stenosis assessed by coronary angiography. Diabetes Metab. 2020;46:150\u20137. https:\/\/doi.org\/10.1016\/j.diabet.2019.07.006.","journal-title":"Diabetes Metab"},{"key":"3882_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01596-4","volume":"21","author":"PN Jensen","year":"2022","unstructured":"Jensen PN, Fretts AM, Hoofnagle AN, McKnight B, Howard BV, Umans JG, et al. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study. Cardiovasc Diabetol. 2022;21:167. https:\/\/doi.org\/10.1186\/s12933-022-01596-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3882_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020429","volume":"10","author":"E Michelucci","year":"2022","unstructured":"Michelucci E, Rocchiccioli S, Gaggini M, Ndreu R, Berti S, Vassalle C. Ceramides and cardiovascular risk factors, inflammatory parameters and left ventricular function in AMI patients. Biomedicines. 2022;10:429. https:\/\/doi.org\/10.3390\/biomedicines10020429.","journal-title":"Biomedicines"},{"key":"3882_CR25","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1161\/CIRCRESAHA.125.327041","volume":"137","author":"M Benkhoff","year":"2025","unstructured":"Benkhoff M, Vogt J, Schr\u00f6der NH, Hu H, Dannenberg L, Keul P, et al. S1P-loading of CAD-HDL restored impaired HDL-mediated cardioprotection. Circ Res. 2025;137:1371\u20133. https:\/\/doi.org\/10.1161\/CIRCRESAHA.125.327041.","journal-title":"Circ Res"},{"key":"3882_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/hsz-2014-0192","volume":"396","author":"N Pr\u00fcfer","year":"2015","unstructured":"Pr\u00fcfer N, Kleuser B, van der Giet M. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality. Biol Chem. 2015;396:573\u201383. https:\/\/doi.org\/10.1515\/hsz-2014-0192.","journal-title":"Biol Chem"},{"key":"3882_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaa2581","author":"S Galvani","year":"2015","unstructured":"Galvani S, Sanson M, Blaho VA, Swendeman SL, Obinata H, Conger H, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P 1 to limit vascular inflammation. Sci Signal. 2015. https:\/\/doi.org\/10.1126\/scisignal.aaa2581.","journal-title":"Sci Signal"},{"key":"3882_CR28","doi-asserted-by":"publisher","first-page":"44645","DOI":"10.1074\/jbc.M112.423426","volume":"287","author":"BA Wilkerson","year":"2012","unstructured":"Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM. Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier. J Biol Chem. 2012;287:44645\u201353. https:\/\/doi.org\/10.1074\/jbc.M112.423426.","journal-title":"J Biol Chem"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-026-03882-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03882-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-026-03882-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:41:28Z","timestamp":1771422088000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-026-03882-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3882"],"URL":"https:\/\/doi.org\/10.1186\/s40001-026-03882-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University (Ethics approval number: 2019\u20139) and the Ethics Committee of Handan First Hospital (Ethics approval number: 2021\u201325). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"322"}}